B+
Bull case
20%
Probability
Target price
$16.08
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
CMPS
COMPASS PathwaysFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$8.17
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$5.48
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-02-26
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+19.4
Score
AI commentary
Market tone is mixed-to-cautious with wide analyst target dispersion. Recent filings and prospectus activity increased near-term dilution concern; sentiment will remain event-driven around clinical/regulatory milestones.
RankAlpha Sentiment AI - 2026-02-26
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-27catalystAnalyst re-ratings / coverage updatesHigh impact
Near-term analyst target revisions or new coverage could widen or compress the trading range; aggregator snippets show wide dispersion.
2026-08-25eventLate-stage clinical / regulatory milestone (assumed)High impact
Binary COMP360 readout or regulatory milestone could sharply re-rate the stock; no firm public date so an assumed planning date is used (see valuation_check).
2027-02-26catalystCommercial / reimbursement progressHigh impact
Payer engagement, commercialization milestones, or a partnering deal would support multi-period re-rating; timeline and execution risk remain material.
Recommendation
N/A
No formal recommendation provided.
As of 2026-02-26 • Updated nightlySource: Internal modelMethodology